Sales Support:
sales@worldwidemarketreports.com
U.S. :+1-252-477-1362
U.K. :+44-203-949-5508
AUS. : +61-8-7924-7805
INDIA :+91-848-285-0837
Menu Icon Close Icon
Discount sale is live
Discount sale is live
We have an updated report [Version - 2025] available. Kindly sign up to get the sample of the report.

Oncology Biosimilars Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

  • Report Code : 565108
  • Industry : Medical Devices
  • Published On : Nov 2020
  • Pages : 103
  • Publisher : 99strategy
  • Format: Excel and PDF

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Oncology Biosimilars market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Oncology Biosimilars are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Oncology Biosimilars market segmented into
G-CSF
Hematopoietic Agents
Monoclonal Antibodies

Based on the end-use, the global Oncology Biosimilars market classified into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Based on geography, the global Oncology Biosimilars market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Celltrion Inc.
Pfizer Inc.
Biocon
BIOCAD
Apotex Inc.
Dr. Reddy's
Sandoz International GmbH
Intas Pharmaceuticals Ltd.
STADA Arzneimittel AG
Teva Pharmaceutical Industries Ltd

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ONCOLOGY BIOSIMILARS INDUSTRY
2.1 Summary about Oncology Biosimilars Industry
2.2 Oncology Biosimilars Market Trends
2.2.1 Oncology Biosimilars Production & Consumption Trends
2.2.2 Oncology Biosimilars Demand Structure Trends
2.3 Oncology Biosimilars Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 G-CSF
4.2.2 Hematopoietic Agents
4.2.3 Monoclonal Antibodies
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Retail Pharmacies
4.3.2 Hospital Pharmacies
4.3.3 Online Pharmacies
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 G-CSF
5.2.2 Hematopoietic Agents
5.2.3 Monoclonal Antibodies
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Retail Pharmacies
5.3.2 Hospital Pharmacies
5.3.3 Online Pharmacies
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 G-CSF
6.2.2 Hematopoietic Agents
6.2.3 Monoclonal Antibodies
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Retail Pharmacies
6.3.2 Hospital Pharmacies
6.3.3 Online Pharmacies
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 G-CSF
7.2.2 Hematopoietic Agents
7.2.3 Monoclonal Antibodies
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Retail Pharmacies
7.3.2 Hospital Pharmacies
7.3.3 Online Pharmacies
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 G-CSF
8.2.2 Hematopoietic Agents
8.2.3 Monoclonal Antibodies
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Retail Pharmacies
8.3.2 Hospital Pharmacies
8.3.3 Online Pharmacies
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 G-CSF
9.2.2 Hematopoietic Agents
9.2.3 Monoclonal Antibodies
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Retail Pharmacies
9.3.2 Hospital Pharmacies
9.3.3 Online Pharmacies
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Celltrion Inc.
10.1.2 Pfizer Inc.
10.1.3 Biocon
10.1.4 BIOCAD
10.1.5 Apotex Inc.
10.1.6 Dr. Reddy's
10.1.7 Sandoz International GmbH
10.1.8 Intas Pharmaceuticals Ltd.
10.1.9 STADA Arzneimittel AG
10.1.10 Teva Pharmaceutical Industries Ltd
10.2 Oncology Biosimilars Sales Date of Major Players (2017-2020e)
10.2.1 Celltrion Inc.
10.2.2 Pfizer Inc.
10.2.3 Biocon
10.2.4 BIOCAD
10.2.5 Apotex Inc.
10.2.6 Dr. Reddy's
10.2.7 Sandoz International GmbH
10.2.8 Intas Pharmaceuticals Ltd.
10.2.9 STADA Arzneimittel AG
10.2.10 Teva Pharmaceutical Industries Ltd
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
Table Oncology Biosimilars Product Type Overview
Table Oncology Biosimilars Product Type Market Share List
Table Oncology Biosimilars Product Type of Major Players
Table Brief Introduction of Celltrion Inc.
Table Brief Introduction of Pfizer Inc.
Table Brief Introduction of Biocon
Table Brief Introduction of BIOCAD
Table Brief Introduction of Apotex Inc.
Table Brief Introduction of Dr. Reddy's
Table Brief Introduction of Sandoz International GmbH
Table Brief Introduction of Intas Pharmaceuticals Ltd.
Table Brief Introduction of STADA Arzneimittel AG
Table Brief Introduction of Teva Pharmaceutical Industries Ltd
Table Products & Services of Celltrion Inc.
Table Products & Services of Pfizer Inc.
Table Products & Services of Biocon
Table Products & Services of BIOCAD
Table Products & Services of Apotex Inc.
Table Products & Services of Dr. Reddy's
Table Products & Services of Sandoz International GmbH
Table Products & Services of Intas Pharmaceuticals Ltd.
Table Products & Services of STADA Arzneimittel AG
Table Products & Services of Teva Pharmaceutical Industries Ltd
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Oncology Biosimilars Market Forecast (Million USD) by Region 2021f-2026f
Table Global Oncology Biosimilars Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Oncology Biosimilars Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Oncology Biosimilars Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
Figure Global Oncology Biosimilars Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oncology Biosimilars Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oncology Biosimilars Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oncology Biosimilars Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Oncology Biosimilars Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Oncology Biosimilars Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Oncology Biosimilars Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure G-CSF Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hematopoietic Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure G-CSF Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hematopoietic Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure G-CSF Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hematopoietic Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure G-CSF Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hematopoietic Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure G-CSF Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hematopoietic Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure G-CSF Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hematopoietic Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Monoclonal Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Biosimilars Sales Revenue (Million USD) of Celltrion Inc. 2017-2020e
Figure Oncology Biosimilars Sales Revenue (Million USD) of Pfizer Inc. 2017-2020e
Figure Oncology Biosimilars Sales Revenue (Million USD) of Biocon 2017-2020e
Figure Oncology Biosimilars Sales Revenue (Million USD) of BIOCAD 2017-2020e
Figure Oncology Biosimilars Sales Revenue (Million USD) of Apotex Inc. 2017-2020e
Figure Oncology Biosimilars Sales Revenue (Million USD) of Dr. Reddy's 2017-2020e
Figure Oncology Biosimilars Sales Revenue (Million USD) of Sandoz International GmbH 2017-2020e
Figure Oncology Biosimilars Sales Revenue (Million USD) of Intas Pharmaceuticals Ltd. 2017-2020e
Figure Oncology Biosimilars Sales Revenue (Million USD) of STADA Arzneimittel AG 2017-2020e
Figure Oncology Biosimilars Sales Revenue (Million USD) of Teva Pharmaceutical Industries Ltd 2017-2020e

Happy To Assist You

We are happy to help! Call or write to us

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides an industry forecast. The market was valued at US$ xxx million in 2025, and is expected to grow at a CAGR of xx% during the period 2025–2032.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
  • Types
  • Applications
  • Technology
  • End-use Industries
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers and restraints
  • Regulatory scenario
  • Industry trend
  • Pestle analysis
  • Porter’s analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Competitive landscape
It helps the businesses in making strategic decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Var Worldwide Market Reports Pvt Ltd, 402, Bremen Business Center, University Road, Pune-411007,India.

phoneiconU.S. : +1-252-477-1362

phoneiconU.K. :+44-203-949-5508

phoneiconAUS. :+61-8-7924-7805

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By
paymenticon
Connect Us
© 2025 Worldwide Market Reports. All Rights Reserved